prethcamide

{{Short description|Respiratory stimulant drug}}

{{Drugbox

| verifiedrevid = 444064499

| image = cropropamide.png

| width = 150px

| image2 = crotethamide.png

| width2 = 150px

| type = combo

| component1 = cropropamide

| class1 =

| component2 = crotethamide

| class2 =

| tradename = Micoren

| pregnancy_AU =

| pregnancy_US =

| pregnancy_category =

| legal_AU =

| legal_CA =

| legal_UK =

| legal_US =

| legal_status =

| routes_of_administration =

| CAS_number = 8015-51-8

| ATC_prefix = R07

| ATC_suffix = AB06

| PubChem = 71672

| ChemSpiderID = 5020604

| DrugBank_Ref = {{drugbankcite|correct|drugbank}}

| DrugBank =

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = 41A1FCW148

| C = 25

| H = 46

| N = 4

| O = 4

}}

Prethcamide, sold under the brand name Micoren, is a respiratory stimulant composed of two related drugs, cropropamide and crotethamide. It was developed by Ciba-Geigy.{{cite journal | vauthors = Potier A | date = 1956 | title = Étude expérimentale chez l'homme d'un nouveau analéptique—le Micorène (Geigy) | journal =Rev Med de la Suisse-Romande | trans-title = Human Experimental Study of a New Analeptic — Micorene (Geigy) | language = French | volume = 76 | pages = 1173 }}{{cite journal | vauthors = Spiegel P, Carvalho AF, Faierchtein S | date = April 1962 | url = http://www.rba.periodikos.com.br/article/5f9dbdaf8e6f1a8a098b463b | title = Double blind clinical study with prethcamide (Micoren-Geigy) | journal = Rev Bras Anest | volume = 12 | issue = 1 | pages = 33–9 }}